US Stock MarketDetailed Quotes
CENBF CEN BIOTECH INC
- 0.000100
- 0.0000000.00%
15min DelayClose Nov 5 16:00 ET
- 0.000100
- 0.0000000.00%
Post 16:09 ET
6.53KMarket Cap-2P/E (TTM)
0.000000High0.000000Low80Volume0.000100Open0.000100Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)65.26MShares0.01860052wk High0.00P/B3.08KFloat Cap0.00000152wk Low--Dividend TTM30.78MShs Float1.525000Historical High--Div YieldTTM0.00%Amplitude0.000001Historical Low0.000000Avg Price1Lot Size
CEN BIOTECH INC Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | (Q3)Sep 30, 2021 | (Q2)Jun 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 399.22%102.34K | 0.00%-335.5K | 321.14%175.75K | -520.61%-90.15K | -175.21%-386.91K | 75.01%-34.2K | 1.54%-335.5K | -235.72%-79.47K | 113.92%21.43K | -115.94%-140.59K |
| Net income from continuing operations | -54.86%-400.89K | 91.99%-1.51M | 76.43%-487.48K | 41.55%-420.19K | 97.75%-348.28K | 58.45%-258.87K | -232.66%-18.9M | -110.81%-2.07M | 62.68%-718.94K | -833.39%-15.49M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | 100.13%27.73K | 100.04%7.45K | -111.01%-35.65K | -51.83%31.2K |
| Depreciation and amortization | -84.78%14.28K | 5.94%489.11K | 56.96%169.17K | 41.94%200.88K | -76.27%25.2K | -11.63%93.86K | 6.01%461.71K | 1.48%107.78K | 31.36%141.52K | -4.15%106.2K |
| Deferred tax | --0 | --0 | ---- | ---- | ---- | ---2.74K | ---2.74K | ---- | ---- | ---- |
| Other non cash items | ---- | -83.63%302.6K | -79.90%297.57K | --0 | 90.24%-13.1K | -87.32%18.13K | 56.17%1.85M | 102.13%1.48M | 61.58%359.24K | -168.64%-134.17K |
| Change In working capital | 249.41%320.06K | -119.61%-165.07K | -356.33%-210.24K | -108.41%-16.78K | -110.89%-29.64K | -68.19%91.6K | -78.32%841.76K | -92.00%82.02K | -78.36%199.51K | -73.49%272.27K |
| -Change in receivables | 225.67%62.16K | -72.24%28.75K | -634.83%-147.66K | 93.51%66.31K | 242.11%159.56K | -215.76%-49.47K | -66.61%103.54K | -112.11%-20.09K | -50.43%34.27K | -39.55%46.64K |
| -Change in prepaid assets | --0 | 241.31%23.96K | 34.56%-32.22K | 87.60%45.42K | 21.31%9.8K | --966 | ---16.96K | ---49.24K | --24.21K | --8.08K |
| -Change in payables and accrued expense | 90.03%256.09K | -83.63%119.45K | 47.67%276.03K | -248.59%-118.56K | -179.42%-172.78K | -45.04%134.77K | -79.58%729.5K | -78.26%186.93K | -90.64%79.79K | -77.10%217.56K |
| -Change in other current liabilities | ---- | ---- | ---- | ---10.97K | ---- | ---- | ---- | ---- | --0 | --0 |
| -Change in other working capital | -66.23%1.8K | -1,413.71%-337.23K | -851.03%-338.24K | ---- | ---- | --5.33K | --25.67K | ---35.57K | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 276.38%102.34K | 0.00%-335.5K | 321.15%175.75K | -520.63%-90.15K | -67.84%-363.09K | 5.08%-58.02K | 1.54%-335.5K | -235.72%-79.47K | 113.92%21.43K | -232.29%-216.34K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -49.65K | 0.00%9.94K | 117.50%9.94K | 0 | 0 | 0 | 107.64%9.94K | -111.12%-56.79K | 280.94%186.73K | -70K |
| Capital expenditure reported | ---49.65K | 0.00%-106.32K | ---- | ---- | ---- | --0 | ---106.32K | ---52.57K | ---- | ---- |
| Net PPE purchase and sale | ---- | 0.00%-23.21K | ---- | ---- | ---- | ---- | -1,388.90%-23.21K | ---4.23K | ---- | ---- |
| Net business purchase and sale | ---- | 0.00%259.47K | --259.47K | ---- | ---- | ---- | --259.47K | --0 | ---- | ---- |
| Net other investing changes | ---- | 0.00%-120K | ---- | ---- | ---- | ---- | 9.02%-120K | --0 | --0 | ---170K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---49.65K | 0.00%9.94K | 117.50%9.94K | --0 | --0 | --0 | 107.64%9.94K | -111.12%-56.79K | 280.94%186.73K | ---170K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 0.00%520.83K | -50.61%54.32K | -321.13%-9.81K | 60.70%476.31K | 0 | 11.05%520.83K | 466.67%110K | -98.22%4.44K | 311.66%296.4K |
| Net issuance payments of debt | --0 | 0.00%520.83K | 234.62%368.08K | 1,765.84%82.75K | -76.38%70K | --0 | 11.05%520.83K | 466.67%110K | -98.22%4.44K | 311.66%296.4K |
| Net other financing activities | ---- | ---- | ---- | ---92.56K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 0.00%520.83K | -50.61%54.32K | -321.13%-9.81K | 60.70%476.31K | --0 | 11.05%520.83K | 466.67%110K | -98.22%4.44K | 311.66%296.4K |
| Net cash flow | ||||||||||
| Beginning cash position | -56.73%83.6K | 0.00%1.91K | -30.71%148.15K | 509.28%66.05K | 17,230.51%135.18K | 10,025.68%193.2K | -49.21%1.91K | 84,743.25%213.81K | 28.44%10.84K | -49.48%780 |
| Current changes in cash | 190.81%52.69K | 0.00%195.26K | 1,014.91%240.31K | -147.16%-100.25K | 1,025.51%113.23K | -5,043.62%-58.02K | 10,660.47%195.26K | -1,686.11%-26.27K | 2,696.45%212.6K | 45.88%10.06K |
| Effect of exchange rate changes | --0 | 0.00%-3.97K | ---- | ---- | ---- | --0 | ---3.97K | --5.66K | ---- | ---- |
| End cash Position | 0.82%136.29K | 0.00%193.2K | 0.00%193.2K | -30.71%148.15K | 509.28%66.05K | 17,230.51%135.18K | 10,025.68%193.2K | 10,025.68%193.2K | 84,743.25%213.81K | 28.44%10.84K |
| Free cash flow | 190.81%52.69K | 0.00%-465.04K | 133.92%46.22K | -75.70%-90.15K | -67.84%-363.09K | 5.08%-58.02K | -36.47%-465.04K | -332.71%-136.27K | 66.68%-51.31K | -232.29%-216.34K |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data